Does femtech suggest so-called women's troubles might soon be taken as seriously as men's?
crypto
-focused, the other concerns the cryptic state of
women's health
, a market projected to be worth $97 billion (€83 billion) by 2030, according to a
recent Irish report
. The authors want to position
Ireland
as a leader in gendered health tech. In Ireland, 30 start-ups, many women-led, are innovating in areas such as
endometriosis
, polycystic ovary syndrome and
menopause
.
We all know the phrase: 'If childbirth/periods/perimenopausal symptoms [insert women's health variable here] were a man's problem, it would have been solved by now.' Does femtech suggest so-called women's troubles might soon be taken as seriously as men's?
As things stand, the history of gendered health tech is one of not enough data (and not enough women). Take the contraceptive pill, marketed in the 1960s after a decade of trials in Puerto Rico. Enovid was designed as a 'universal' contraceptive, a one-size-fits-all that ignored women's diverse bodies and needs.
And who was the contraceptive pill really designed for? Its 21 days of hormones followed by a seven-day withdrawal bleed were a deliberate choice to mimic 'natural' menstrual cycles, making it more palatable, not just to users, but also to religious institutions. Dr John Rock, a devout Catholic who co-developed the contraceptive, acted in the misguided hope that the bleed would align the pill more closely with the rhythm method in the eyes of the church.
READ MORE
Healthcare in general suffers from what Catherine D'Ignazio, the author of Data Feminism, has called the gender data gap. Between the 1970s and the 1990s, an FDA (US
Food and Drug Administration) guidance excluded women of childbearing age from early-stage clinical trials. The result is that many drugs were optimised by default for male bodies, with no research into how sex differences might affect drug metabolism, dosage or side effects.
[
Femtech is about finally prioritising women's health in a world focused on men
Opens in new window
]
Then there's the speculum, a gynaecological instrument created with the user in mind – aka, a clinician, not the patient. These are just a few examples in a long history of health technologies designed for women without really considering how women and their bodies respond.
Health tech has a habit of treating the user as a genderless everybody, which in practice usually means young, white, able-bodied, well-educated men, reflecting the designer's own demographic group. And it's not just health tech either: VR headsets, PPE, crash-test dummies, even musical instruments are built for male bodies.
The problem isn't always a lack of data. Sometimes, it's too much of the wrong kind. The pill was tested in Puerto Rico because population control programmes were already in place, funded by US philanthropy. J Marrion Sims, known as the father of modern gynaecology, developed today's bivalve speculum while undertaking experimental surgeries on enslaved African women without consent or anaesthetic.
In the mid-20th century, US venereal disease registries enabled the detention of women under public health laws. Henrietta Lacks, an African-American cancer patient at Johns Hopkins in the 1950s, had her cancer cells taken without her consent. They became the immortal HeLa cell line, used in countless medical breakthroughs. Her family received no compensation.
In Ireland, the Magdalene laundries kept records of 'fallen women' for moral surveillance, not maternal care. Today, period and fertility-tracking apps raise similar concerns: in 2021, the Federal Trade Commission in the US charged the Flo app with sharing sensitive data with Facebook, Google and analytics firms, despite promising privacy. In the US, there are now fears such data could be subpoenaed in states where abortion is criminalised.
The femtech gold rush promises to undo these wrongs, promising to keep central personalised design, diverse user input, and lived experience in product development. Ireland is already taking steps to ensure women's health innovation isn't left entirely to market forces. As the Femtech in Ireland: The Case for Prioritising Women's Health Research and Innovation report notes, women's health is 'a billion-dollar opportunity,' and 'smart economics', but it's also an area where public support has delivered real results.
[
Ireland has potential to become global leader in femtech, report says
Opens in new window
]
Through programmes such as Femtech @ Health Innovation Hub Ireland, Horizon 2020, and Enterprise Ireland seed funding, dozens of Irish companies have been able to bring early-stage ideas into clinical testing, from Coroflo's real-time breast-milk monitor to IdentifyHer's wearable menopause sensor. This public backing centres
women's health in national innovation strategy. It proves the viability of solutions for historically under-researched conditions.
But once companies move from research and prototyping to a scaled product, private capital becomes essential. Coroflo raised $2.8 million from private investors; IdentifyHer is currently seeking pre-seed funding. Venture capital can accelerate growth, but as tech writer Edward Ongweso argues, it doesn't necessarily fund what's best, socially or holistically, raising questions about what values get built into women's health tech and who will be able to afford new advances.
Privacy is another concern. In 2012, Target made headlines for predicting a teenager's pregnancy based on her purchasing data, sending her baby-product offers before she had told her family. Pregnancy data is extremely lucrative – worth two or three times that of a 'general' consumer – because it signals future spending. Menopause, long under-researched, is another rich data set, flagging future health needs and spending patterns.
Much of the data gathered by femtech companies is proprietary, giving whoever collects it a first-mover advantage when it comes to developing drugs, therapies or insurance products. Proprietary data can mean commercial incentives, with no benefit to those being studied, from resale to insurers to invasive advertising (women over 35 are already plagued by ads for mushroom and flax supplements on Instagram). And, as any open-source advocate will tell you, it also means less public benefit; valuable health insights aren't always shared if they form part of a company's intellectual property.
Ireland has already shown that sustained, targeted public support can lead to meaningful innovation in women's health. The challenge now is to keep momentum beyond the start-up phase, so that femtech in Ireland doesn't just mirror short-term venture capital cycles, but grows into a genuine revolution in women's care.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Irish Times
7 hours ago
- Irish Times
A close shave: Colm Keena on the trials and tribulations of a summer job in St James's hospital
A while ago, while telling a friend about the job I got during the summer after I left school, he appeared shocked when I mentioned that, among other duties, I'd shaved a dead man. The job was that of ward orderly in James St Hospital, Dublin. It was reasonably well paid and came with the bonus of working alongside a load of female student nurses. I was working in the geriatric wards and, still years away from having to shave myself, one of my duties was shaving the patients. This quickly became the cause of some anxiety, not for me, but for the poor patients. The equipment comprised a plastic basin, a bar of soap, a shaving brush, and a razor. After my first few outings, I added a roll of loo paper. I'd soap the men's faces, then set to work with the razor, often as the patient and I indulged in friendly banter. The problem was the nicks. I'd be shaving away and then I'd feel it, the nick, and the patient would too, as evidenced by their flinch. A dribble of blood would begin to mingle with the lather on their cheek as I tore off some loo paper and used it to stem the flow. READ MORE Sweeny Todd, one of the men kindly called me, referring to the fictional London barber who used to murder his customers. One of older wards had six to eight beds on each side of a long, wide room and I have a memory of surveying my morning's work and seeing an array of older men in striped cotton pyjamas, all with brave smiles, the shakes, and spots of bloodied loo paper stuck to their faces. I have no memory of any complaints, and a hazy view that, despite the nicks, they wished me well. Ireland, back then, was a less litigious place. As already mentioned, one of the upsides to the job was the student nurses. I was hugely shy and both delighted and terrified to be working with them. I had lots of different jobs, including giving the men baths, helping with meals, and helping the nurses with various unskilled nursing chores. One day, a few weeks into the job, a nurse came up to me and told me to stop what I was doing and go shave Mr X, who was in another ward. There were some visitors nearby and I motioned the nurse to one side and, speaking quietly, conveyed what I thought was important news. 'Mr X is dead.' She looked at me as if there was no bottom to my stupidity. 'I know he's dead. That's why I want you to shave him.' I fetched my equipment and off I went. The curtains were drawn around the dead man's bed and when I stepped inside it was just me and him. Someone had placed a ribbon around his head to hold his jaw in place until rigor mortis set in. It felt a bit weird, being there, in a tight space, with the body of a man I'd washed and fed over the previous days and weeks. But I decided to get on with it. I removed the ribbon, lathered his face, and started to shave. Pretty soon I felt it, a nick, and I stopped. But no blood emerged. Ah, I said to myself, as the penny dropped. No blood flow. And I proceeded to give him a good close shave. Curiously enough, I felt glad of the opportunity to do him the service. As I remember it, there was quite a good atmosphere on the wards, among both the staff and the patients. Everything I've seen in the years since has bolstered the idea that caring for others, and thereby not having the time to fixate on your own needs, makes humans happy. When doing so as a team, this creates its own, special atmosphere, so that even those receiving the care are positively affected. Or so it seems to me, Sweeny Todd.
Irish Times
11 hours ago
- Irish Times
Assessments of children who may have had unnecessary hip surgeries pushed back to next year
Children who may have been subjected to unnecessary hip dysplasia surgery must wait until next year before they are assessed by a team of external experts for a second medical opinion. In May, the HSE published an independent audit on hip surgery thresholds for children with developmental dysplasia of the hip. It examined 147 cases across three hospitals : Temple Street , the National Orthopaedic Hospital Cappagh and Crumlin Hospital . In Temple Street, 60 per cent of surgeries audited did not meet the clinical threshold for surgical intervention, while this was the case for 79 per cent in the Cappagh hospital. Following the report, the HSE announced it was commissioning an independent expert review panel that will work to review patient files to determine the appropriateness of the original decision to operate. READ MORE The HSE said then that the review panel would be set up within six months. However, a spokeswoman for the executive has now said it will be January before the review of individual cases begins. The health service issued an international call for experts, with applications accepted up until last Friday. 'Expressions of interest have been received from a wide range of regions including Ireland, the UK , the USA , Canada , Asia and other parts of Europe,' the spokeswoman said. 'These submissions will be subject to a shortlisting and recruitment process prior to the formal announcement of the panel, which is expected to convene in September.' She said an international expert has been identified and agreed to chair the external panel, and terms are being negotiated. The organisation is designing a 'robust scientific and methodological framework' for the review, which is expected to be agreed between September and December this year. 'It is expected that the review of individual cases will commence in January. This timeline reflects the complexity of the work involved and the need to ensure a rigorous and comprehensive approach,' it added. The HSE, Children's Health Ireland (CHI) and patient advocates held a meeting on the external review panel last Thursday. In a statement following the meeting, Hip Dysplasia Advocacy Group, a newly-established representative organisation, said there must be 'full transparency' between the HSE and the families regarding these reviews. It said 'everyone is left completely in the dark'. 'We strongly suggested they set up a webpage to inform families of updates in a timely manner and we hope to see this implemented swiftly,' the statement said. The advocacy group described the engagement with CHI at the meeting as positive, adding that the paediatric healthcare provider anticipates all follow-up appointments for affected children will be completed by the end of the year.
Irish Times
19 hours ago
- Irish Times
Why do my potatoes look warty – and are they safe to eat?
Why is the skin of my home-grown potatoes covered in patches of what almost looks like a rough, warty growth, and are they still safe to eat? Andrew Cullinane, Co Galway It sounds as if your potatoes have a disease known as common scab. The good news is that while it sounds horrible and looks unsightly, it doesn't affect the flavour or edibility of the tubers themselves. Symptoms of common scab, which is naturally present in many soils as a microorganism known as Streptomyces scabium, are exacerbated by the developing baby potatoes being exposed to periods of sustained dry weather like those experienced in Ireland this spring and summer. It's also more likely to affect potatoes grown in a limy soil, or a soil to which lime has recently been applied. The rough, scabby growth on the skin of your potatoes is actually the plant's way of limiting damage to the flesh of the tubers. There is no treatment for this disease, which can also be inadvertently introduced into a garden or allotment by way of infected seed potatoes. For this reason, it's always recommended to source the latter from reliable suppliers as certified free from disease. It's also a good idea to keep young plants sufficiently watered during any prolonged dry spells. Crop rotation will help too, by preventing a build-up of the disease in the soil. READ MORE It's worth noting that some varieties, typically those with thinner skins, are more vulnerable to common scab than others. Examples of varieties with good resistance to the disease include 'Connect' (maincrop); 'Cammeo' (maincrop) and 'Charlotte' (early). Importantly, all these varieties also have good resistance to blight, a far more destructive disease that can wipe out an entire crop in a bad year. [ Is it too late to save my blighted potato plants? Opens in new window ] If your potatoes are a maincrop variety that you're planning on storing to use over the coming months, then take extra care to give them a cool, dark, dry spot to reduce the possibility of the scabbed areas of the tubers becoming infected by soft rot, which could then spread to the rest of the potatoes and destroy them. For the same reason, make sure to examine the stored tubers regularly to check for any early signs of rot, discarding any that you find (but not in the compost heap). Finally, for obvious reasons, also avoid reusing any of them as seed potatoes next spring. An interesting footnote to the above is that the microorganism that causes common scab in potatoes belongs to the same Streptomyces genus that's also played a vital role in the production of the majority of antibiotics. Just a few years ago, a new soil-dwelling species of Streptomyces was discovered by scientists in west Fermanagh, which promises significant potential as a new generation of antibiotic. How amazing is that?
